CSS
DXCM icon

Cubist Systematic Strategies’s DexCom DXCM Stock Holding History

Cubist Systematic Strategies’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.13M Sell
91,100
-42,000
-32% -$3.32M 0.03% 844
2025
Q2 		$11.6M Buy
133,100
+114,400
+612% +$8.97M 0.05% 527
2025
Q1 		$1.28M Buy
18,700
+1,100
+6% +$89.8K 0.01% 1686
2024
Q4 		$1.37M Sell
17,600
-17,200
-49% -$1.27M 0.01% 1614
2024
Q3 		$2.33M Sell
34,800
-51,800
-60% -$4.25M 0.01% 1339
2024
Q2 		$9.82M Sell
86,600
-112,500
-57% -$14.2M 0.07% 423
2024
Q1 		$27.6M Buy
199,100
+12,500
+7% +$1.57M 0.16% 103
2023
Q4 		$23.2M Buy
186,600
+148,700
+392% +$15.2M 0.15% 120
2023
Q3 		$3.54M Buy
37,900
+25,700
+211% +$2.9M 0.03% 975
2023
Q2 		$1.57M Buy
12,200
+1,800
+17% +$218K 0.01% 1666
2023
Q1 		$1.21M Buy
10,400
+2,000
+24% +$224K 0.01% 2032
2022
Q4 		$951K Sell
8,400
-66,500
-89% -$7.3M 0.01% 2494
2022
Q3 		$6.03M Sell
74,900
-3,600
-5% -$305K 0.03% 898
2022
Q2 		$5.85M Buy
+78,500
New +$7.16M 0.04% 844

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cubist Systematic Strategies's DXCM Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in DexCom (DXCM) in Q3 2025: 474,151 shares worth $31.9M. The stake represents 0.15% of the portfolio and ranks #142 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in DXCM as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in DXCM in Q2 2014 and has held it in 41 quarters since. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Cubist Systematic Strategies held 474,151 shares of DexCom worth $31.9M as of Q3 2025.
  • DexCom was a new Cubist Systematic Strategies position in Q3 2025.
  • DexCom made up 0.15% of Cubist Systematic Strategies's portfolio in Q3 2025, its #142 holding.
  • Cubist Systematic Strategies first reported a position in DexCom in Q2 2014 and has held it in 41 quarters since.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.